← NOVARTIS AG
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Goodwill | $31.0b | $31.8b | $35.3b | $26.5b | $30.0b | $29.6b | $29.3b | $23.3b | $24.8b | $25.6b | |
| Intangible Assets Other Than Goodwill | $31.3b | $30.0b | $38.7b | $28.8b | $36.8b | $34.2b | $31.6b | $26.9b | $26.9b | $29.4b | |
| Additional Financial Items | |||||||||||
| Current Tax Assets Current | — | — | — | — | $239.0m | $278.0m | $268.0m | $426.0m | $133.0m | $205.0m | |
| Current Tax Liabilities Current | $1.6b | $1.7b | $2.0b | $2.2b | $2.5b | $2.4b | $2.5b | $1.9b | $1.6b | $2.0b | |
| Deferred Tax Assets | $10.0b | $8.2b | $8.7b | $7.9b | $8.2b | $3.7b | $3.7b | $4.3b | $4.4b | $5.4b | |
| Issued Capital | $972.0m | $969.0m | $944.0m | $936.0m | $913.0m | $901.0m | $890.0m | $825.0m | $793.0m | $766.0m | |
| Total Assets | $130.1b | $133.1b | $145.6b | $118.4b | $132.1b | $131.8b | $117.5b | $99.9b | $102.2b | $110.9b | |
| LIABILITIES AND EQUITY | |||||||||||
| Deferred Tax Liabilities | $6.7b | $5.2b | $7.5b | $5.9b | $7.4b | $3.1b | $2.7b | $2.2b | $2.4b | $3.4b | |
| Deferred Tax Liability Asset | ($3.4b) | ($3.1b) | — | — | ($792.0m) | ($673.0m) | ($1.1b) | ($2.1b) | ($1.9b) | ($2.0b) | |
| Increase Decrease Through Business Combinations Deferred Tax Liability Asset | ($336.0m) | ($317.0m) | $2.5b | $47.0m | $1.5b | $46.0m | $244.0m | — | — | — | |
| Total Liabilities | $55.2b | $58.9b | $66.9b | $62.8b | $75.4b | $64.0b | $58.0b | $53.2b | $58.1b | $64.4b | |
| Noncontrolling Interests | $59.0m | $59.0m | $78.0m | $77.0m | $68.0m | $167.0m | $81.0m | $83.0m | $80.0m | $419.0m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.